REQUEST A DEMO
Total
USD $0.00
Search more companies

Novelix Pharmaceuticals Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Novelix Pharmaceuticals Ltd. Profile Updated: December 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Trimurthi Drugs & Pharmaceuticals Ltd. operates in the generic drug industry. Trimurthi Drugs is engaged in manufacturing, distribution, marketing and trading of pharmaceutical products. Trimurthi Drugs is listed in Bombay Stock Exchange and Ahmedabad Stock Exchange. The company was founded in 1976 and based in Hyderabad, India.

Legal Address
Amrutha Estates, 6th floor,, H.No. 3-6-237/610, Lingapur LA Builders
Hyderabad; Telangana; Postal Code: 500029

Contact Details: Purchase the Novelix Pharmaceuticals Ltd. report to view the information.

Website: http://www.trimurthidrugs.com

Basic Information
Total Employees:
Purchase the Novelix Pharmaceuticals Ltd. report to view the information.
Outstanding Shares:
Purchase the Novelix Pharmaceuticals Ltd. report to view the information.
Registered Capital:
Purchase the Novelix Pharmaceuticals Ltd. report to view the information.
Financial Auditors:
Purchase the Novelix Pharmaceuticals Ltd. report to view the information.
Incorporation Date:
1976
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Chairman & Managing Director
Purchase this report to view the information.
Non Executive Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
66.56%
Purchase this report to view the information.
20.12%
Purchase this report to view the information.
13.32%
Purchase this report to view the information.
Subsidiaries
Trimurthi Foods Ltd.
100%
Trimurthi Pharmaceuticals India Pvt.Ltd.
59%
Company Performance
Financial values in the chart are available after Novelix Pharmaceuticals Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
58.14%
Total operating revenue
53.69%
Operating profit (EBIT)
3.54%
EBITDA
-1.88%
Net Profit (Loss) for the Period
5.2%
Total assets
69.6%
Total equity
27.16%
Operating Profit Margin (ROS)
3.02%
Net Profit Margin
3.29%
Return on Equity (ROE)
0.85%
Quick Ratio
-17.27%
Cash Ratio
-17.26%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?